Futura Medical plc (LON:FUM – Get Free Report) fell 2.2% during mid-day trading on Thursday . The stock traded as low as GBX 2.09 and last traded at GBX 2.20. 1,432,718 shares traded hands during trading, an increase of 25% from the average session volume of 1,149,129 shares. The stock had previously closed at GBX 2.25.
Futura Medical Trading Down 20.7%
The stock has a market cap of £5.31 million, a P/E ratio of -0.84 and a beta of 1.25. The business’s fifty day simple moving average is GBX 4.38 and its 200 day simple moving average is GBX 7.76.
Futura Medical (LON:FUM – Get Free Report) last announced its earnings results on Tuesday, September 30th. The company reported GBX (2.17) earnings per share for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. On average, analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.
Futura Medical Company Profile
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.
Read More
- Five stocks we like better than Futura Medical
- What Do S&P 500 Stocks Tell Investors About the Market?
- Rare Earth Stocks: The Truce That Isn’t a Truce
- Stock Market Sectors: What Are They and How Many Are There?
- Carving Up Profits: 3 Food Stocks on the Thanksgiving Table
- Where to Find Earnings Call Transcripts
- C3.ai’s Reset: Why New Leadership Could Spark a Turnaround
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
